Senate Judiciary Importation Hearing
This article was originally published in The Pink Sheet Daily
The Senate Judiciary Committee will hold a hearing on drug importation July 14
You may also be interested in...
Sen. Hatch asks FDA's Crawford and Troy to be ready to testify on reimportation. Bioterrorism bill includes intellectual property provisions.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.